<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04630171</url>
  </required_header>
  <id_info>
    <org_study_id>STU00213282</org_study_id>
    <nct_id>NCT04630171</nct_id>
  </id_info>
  <brief_title>VerTouch Device: A Prospective Randomized Controlled Trial</brief_title>
  <official_title>Does the VerTouch Device Improve Insertion Site Identification for Lumbar Neuraxial Procedures When Compared to Palpation or Ultrasound Guided Site Selection? A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Intuitap</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the VerTouch device to palpation and ultrasound (US) techniques used&#xD;
      to identifying the anatomic landmarks and optimal location for neuraxial access. This trial&#xD;
      of the VerTouch device will be compared to the gold standard of palpatoin and the commonly&#xD;
      cited US techniques.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thousands of neuraxial procedures are completed daily with over 12,000 done at Prentice&#xD;
      Women's hospital last year. These procedures are not without difficulty and complication. The&#xD;
      gold standard of palpation and blind advancement of the needle toward the spine can result in&#xD;
      multiple insertions of the needle into the skin and redirections of the trajectory of that&#xD;
      needle after insertion to avoid the bones of the spine protecting the spinal column. These&#xD;
      insertions and redirections are not only time consuming while the patient is in an uncommon&#xD;
      position, but they also cause dis-comfort and possibly lasting pain days after the procedure.&#xD;
      In addition to the patient dynamics, when anatomical or positioning issues result in&#xD;
      difficult neuraxial procedures the common teaching is to attempt US guided access.&#xD;
      Unfortunately, not many proceduralist are trained in this modality and the additional&#xD;
      materials needed to perform the procedure with US take time to gather and further prolong the&#xD;
      procedure. Additionally, though the cost of US technology is getting more reasonable, it is&#xD;
      still rather expensive and a barrier to utilization by many facilities around the country and&#xD;
      the world. Often, after many attempts, the proceduralist accepts failure of the procedure and&#xD;
      refers the patient to the interventional radiology (IR) or pain medicine specialist for&#xD;
      completion of the procedure using radiation to visualize the spine. Note, this is not an&#xD;
      option for pregnant women who are not eligible for radiation due to fetal concerns.&#xD;
&#xD;
      The VerTouch device offers a non-invasive, untethered, and non-radiation producing device&#xD;
      that allows for the visualization of the underlying structures of the spine to determine&#xD;
      ideal needle placement for neuraxial procedures. The output on the screen can also be&#xD;
      visualized by other providers or senior proceduralist for assistance with best course of&#xD;
      action for the procedure. The device does not cause discomfort to the patient and does not&#xD;
      require any additional materials to be functional.&#xD;
&#xD;
      Study participants will be recruited in two parallel cohorts (pregnant patients and&#xD;
      non-pregnant patients). Pregnant patients tend to be healthy and without comorbidities, and&#xD;
      the anesthesiologists who perform the neuraxial procedure tend to have significant&#xD;
      experience. Non-pregnant patients tend to require neuraxial access for diagnostic or&#xD;
      therapeutic purposes (i.e. not for the relief of labor pains), and therefore have&#xD;
      comorbidities.&#xD;
&#xD;
      Labor &amp; Delivery: Participants will be randomized to one of the three arms (palpation, US, or&#xD;
      VerTouch).&#xD;
&#xD;
      Lumbar Puncture: Participants will be randomized to one of the three arms (palpation, US, or&#xD;
      VerTouch).&#xD;
&#xD;
      This study has the potential to show that the VerTouch is more effective than palpation and&#xD;
      as effective as US at defining the location for neuraxial procedure initiation and eventual&#xD;
      success.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective randomized controlled trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participant will be blinded to what procedure will be used to identify lumbar landmarks.&#xD;
All devices will be in the room with the operator of the devices.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of insertions of the needle</measure>
    <time_frame>End of procedure</time_frame>
    <description>Primary endpoint is the number of insertions of the needle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of redirections of the needle</measure>
    <time_frame>End of procedure</time_frame>
    <description>Primary endpoint is the number of redirections of the needle</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pregnancy</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group 1: VerTouch for labor epidural or spinal anesthesia procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure in women requesting labor analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Ultrasound (US) for labor epidural or spinal anesthesia procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure in women requesting labor analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: Control group, palpation for labor epidural or spinal anesthesia procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure in women requesting labor analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4: VerTouch for lumbar puncture procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VerTouch utilized for identification of site for lumbar puncture procedure in patients who require a therapeutic lumbar puncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5: Ultrasound (US) for lumbar puncture procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound (US) utilized for identification of site for lumbar puncture procedure in patients who require a therapeutic lumbar puncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 6: Control group, palpation for lumbar puncture procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group, palpation utilized for identification of site for lumbar puncture procedure in patients who require a therapeutic lumbar puncture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure</intervention_name>
    <description>Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia</description>
    <arm_group_label>Group 1: VerTouch for labor epidural or spinal anesthesia procedure</arm_group_label>
    <other_name>Group 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure</intervention_name>
    <description>Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia</description>
    <arm_group_label>Group 2: Ultrasound (US) for labor epidural or spinal anesthesia procedure</arm_group_label>
    <other_name>Group 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure</intervention_name>
    <description>Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia</description>
    <arm_group_label>Group 3: Control group, palpation for labor epidural or spinal anesthesia procedure</arm_group_label>
    <other_name>Group 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group #4: VerTouch utilized for identification of site for lumbar puncture procedure</intervention_name>
    <description>Group #4: VerTouch utilized for identification of site for lumbar puncture procedure for patients undergoing a therapeutic lumbar puncture</description>
    <arm_group_label>Group 4: VerTouch for lumbar puncture procedure</arm_group_label>
    <other_name>Group 4</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group #5: Ultrasound (US) utilized for identification of site for lumbar puncture procedure</intervention_name>
    <description>Ultrasound (US) utilized for identification of site for lumbar puncture procedure for patients undergoing a therapeutic lumbar puncture</description>
    <arm_group_label>Group 5: Ultrasound (US) for lumbar puncture procedure</arm_group_label>
    <other_name>Group 5</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group #6: Control group, palpation utilized for identification of site for lumbar puncture procedure</intervention_name>
    <description>Group #6: Control group, palpation utilized for identification of site for lumbar puncture procedure for patients undergoing a therapeutic lumbar puncture</description>
    <arm_group_label>Group 6: Control group, palpation for lumbar puncture procedure</arm_group_label>
    <other_name>Group 6</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients 18 years old and above&#xD;
&#xD;
          -  Undergoing a neuraxial procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non English speaking&#xD;
&#xD;
          -  Plastic allergy&#xD;
&#xD;
          -  Unable to provide written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahesh Vaidyanathan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahesh Vaidyanathan, M.D</last_name>
    <phone>312-472-3585</phone>
    <email>mahesh.vaidyanathan@nm.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital and Prentice Women's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahesh Vaidyanathan, MD</last_name>
      <phone>312-472-3585</phone>
      <email>mahesh.vaidyanathan@nm.org</email>
    </contact>
    <contact_backup>
      <last_name>Paul Fitzgerald, BSN, MS</last_name>
      <phone>312-695-1064</phone>
      <email>p-fitzgerald2@northwestern.du</email>
    </contact_backup>
    <investigator>
      <last_name>Mahesh Vaidyanathan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2020</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Mahesh Vaidyanathan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Neuraxial Anesthesia</keyword>
  <keyword>Therapeutic Lumbar Puncture</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Labor epidural</keyword>
  <keyword>Spinal Procedure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

